Nuvelution Pharma Inc.

Financings Third-quarter 2017 biopharma financing reached $12.5 billion, just a 6% decrease from the previous quarter's $13.4 billion. ( See Exhibit 1. ) The most money was raised in the follow-on pub

Synthorx Inc. ,a biotechnology company using synthetic biology to discover and develop novel protein therapeutics, has named Dr. Laura Shawver president, director and CEO. Prior to joining Syntho

Shire PLC has named Thomas Dittrich CFO and a member of the rare disease specialist's executive committee. Dittrich will assume his roles at Shire in early 2018 after a transition period from hi

IN VITRO DIAGNOSTICS Alliances Angle PLC Qiagen NV Angle PLC and Qiagen NV will co-promote each other’s liquid biopsy solutions for cancer detection. (Sep.) To the deal Angle contributes its